期刊文献+
共找到89篇文章
< 1 2 5 >
每页显示 20 50 100
基于3,5-二溴水杨醛席夫碱镍配合物-氧化石墨烯电化学免疫传感器检测Anti-IgG含量的研究 被引量:2
1
作者 赖丽燕 刘峥 +2 位作者 李巍 周昱 黄红霞 《分析科学学报》 CAS CSCD 北大核心 2014年第4期481-484,共4页
应用物理吸附法将羊抗人IgG抗原直接固定于3,5-二溴水杨醛席夫碱镍配合物-氧化石墨烯修饰的金电极表面,制备电化学免疫传感器。采用循环伏安法和交流阻抗法对传感器进行表征,结果表明该传感器适合检测Anti-IgG浓度。同时探讨了缓冲液pH... 应用物理吸附法将羊抗人IgG抗原直接固定于3,5-二溴水杨醛席夫碱镍配合物-氧化石墨烯修饰的金电极表面,制备电化学免疫传感器。采用循环伏安法和交流阻抗法对传感器进行表征,结果表明该传感器适合检测Anti-IgG浓度。同时探讨了缓冲液pH值、扫描速度、免疫反应温度、抗原与抗体配比对循环伏安峰电流的影响,结果表明在5-100mV/s扫速范围内,峰电流与扫速呈线性。孵育最优条件为25℃,h-IgG与Anti-IgG配比为1∶1。循环伏安法研究还表明Anti-IgG浓度在0.01-260μg/L范围内,线性关系良好,相关系数r^2=0.993,检出限(S/N=3)为0.006μg/L,据此建立了检测Anti-IgG浓度的新方法。 展开更多
关键词 氧化石墨烯 3 5-二溴水杨醛席夫碱镍配合物 anti—IgG 电化学免疫传感器
下载PDF
信号分子IRAK1/4在antiβ-2GPI/β2GPI复合物诱导THP-1细胞表达TF中的作用探讨 被引量:1
2
作者 文海平 周红 +4 位作者 许国莹 郭东琳 周芳 陈东东 解鸿翔 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第4期295-299,共5页
目的:探讨IRAK1和IRAK4在antiβ-2GPI/β2GPI复合物诱导单核细胞株THP-1表达组织因子(TF)中的作用。方法:利用荧光定量PCR(Real-time PCR)、TF活性试剂盒分别检测THP-1细胞表达TF mRNA及TF活性;Western blot检测anti-β2GPI/β2GPI复合... 目的:探讨IRAK1和IRAK4在antiβ-2GPI/β2GPI复合物诱导单核细胞株THP-1表达组织因子(TF)中的作用。方法:利用荧光定量PCR(Real-time PCR)、TF活性试剂盒分别检测THP-1细胞表达TF mRNA及TF活性;Western blot检测anti-β2GPI/β2GPI复合物诱导THP-1细胞表达IRAK1、磷酸化-IRAK1(p-IRAK1)、IRAK4情况;观察IRAK1/4抑制物是否干预anti-β2GPI/β2GPI复合物诱导THP-1表达TF。结果:Antiβ-2GPI/β2GPI复合物(100μg/ml)诱导THP-1细胞表达TF显著增加(P<0.05 vs control);Antiβ-2GPI/β2GPI复合物(100μg/ml)刺激THP-1细胞表达IRAK1、p-IRAK1、IRAK4(蛋白)显著升高(P<0.05 vscontrol);IRAK1/4抑制物(50μmol/L)能够阻断antiβ-2GPI/β2GPI复合物(100μg/ml)诱导THP-1表达TF及IRAK1磷酸化的效应。结论:antiβ-2GPI/β2GPI复合物诱导THP-1细胞表达TF过程中,信号分子IRAK1/4被激活进而发挥重要作用。 展开更多
关键词 抗磷脂综合征 antiβ-2GPI/β2GPI IRAK1 IRAK4 组织因子
下载PDF
三维Anti de Sitter空间中Lorentzian曲面的S_t^1×S_s^1-值光锥Gauss映射的奇点分类
3
作者 于海鸥 高瑞梅 +1 位作者 孔令令 裴东河 《东北师大学报(自然科学版)》 CAS CSCD 北大核心 2010年第4期35-45,共11页
利用Arnol'd的Legendrian理论,对三维Anti de Sitter空间中Lorentzian曲面进行了研究.引入光维高度函数概念研究了三维Anti de Sitter空间Lorentzian曲面的S1t×S1s-值、光锥Gauss映射的奇点,进行了奇点分类,揭示了类光Causs-kr... 利用Arnol'd的Legendrian理论,对三维Anti de Sitter空间中Lorentzian曲面进行了研究.引入光维高度函数概念研究了三维Anti de Sitter空间Lorentzian曲面的S1t×S1s-值、光锥Gauss映射的奇点,进行了奇点分类,揭示了类光Causs-kronecker曲率之间的关系;并研究了Lorentzian曲面的一些基本几何性质. 展开更多
关键词 Lorentzian曲面 三维anti DE SITTER空间 St1×Ss1-值光锥Gauss映射 Lorentzian光维高度函数
下载PDF
Purification and characterization of a novel anti-coagulant from the leech Hirudinaria manillensis 被引量:8
4
作者 Ruo-Mei Cheng Xiao-Peng Tang +5 位作者 Ai-Lin Long James Mwangi Ren Lai Rui-Pu Sun Cheng-Bo Long Zhen-Qing Zhang 《Zoological Research》 SCIE CAS CSCD 2019年第3期205-210,共6页
Protease inhibitors have been reported rarely from the leech Hirudinaria manillensis.In this study,we purified a novel protease inhibitor(bdellin-HM-2)with anticoagulant properties from H.manillensis.With a molecular ... Protease inhibitors have been reported rarely from the leech Hirudinaria manillensis.In this study,we purified a novel protease inhibitor(bdellin-HM-2)with anticoagulant properties from H.manillensis.With a molecular weight of 1.4x104,bdellin-HM-2 was also characterized with three intra?molecular disulfide bridges at the N-terminus and multiple HHXDD and HXDD motifs at theC-terminus.cDNAcloning revealed that the putative nucleotide-encoding protein of bdellin-HM-2 contained 132 ami no acids and was encoded by a 399 bp open reading frame(ORF).Sequence alignment showed that bdellin-HM-2 shared similarity with the“non-classical"Kazal-type serine protease inhibitors,but had no inhibitory effect on trypsin,elastase,chymotrypsin,kallikrein,factor Xlla(FXIIa),factor Xia(FXIa),factor Xa(FXa),thrombin,or plasmin.Bdellin-HM-2 showed anticoagulant effects by proIonging the activated partial thromboplastin time(aPTT),indicating a role in enabling H.manillensis to obtain a blood meal from its host.Our results suggest that bdellin-HM丒2 may play a crucial role in blood-sucking in this leech species and may be a pote ntial can didate for the development of clinical anti-thrombotic drugs. 展开更多
关键词 Hirudinaria manillensis Bdellin-HM-2 "Non-classical"Kazal inhibitors Blood SUCKING antiCOAGULANT anti-thrombotic drugs
下载PDF
Cardiac implications of thrombotic thrombocytopenic purpura 被引量:4
5
作者 Szymon L Wiernek Bo Jiang +1 位作者 Gregory M Gustafson Xuming Dai 《World Journal of Cardiology》 CAS 2018年第12期254-266,共13页
Thrombotic thrombocytopenic purpura(TTP) is a multisystem disorder that essentially can affect any organ in the human body. The hallmark of the pathogenesis in TTP is the large von Willebrand factor multimers on plate... Thrombotic thrombocytopenic purpura(TTP) is a multisystem disorder that essentially can affect any organ in the human body. The hallmark of the pathogenesis in TTP is the large von Willebrand factor multimers on plateletmediated micro-thrombi formation, leading to microvascular thrombosis.Autopsy studies showed that cardiac arrest and myocardial infarction are the most common immediate causes of death in these patients. Clinical manifestations of cardiac involvement in TTP vary dramatically, from asymptomatic elevation of cardiac biomarkers, to heart failure, MI and sudden cardiac death. There is limited knowledge about optimal cardiac evaluation and management in patients with TTP. The absence of typical cardiac symptoms,combined with complicated multi-organ involvement in TTP, may contribute to the under-utilization of cardiac evaluation and treatment. Prompt diagnosis and timely initiation of effective therapy could be critically important in selected cases. Based on our experience and this review of the literature, we developed several recommendations for focused cardiac evaluation for patients with acute TTP:(1) patients with suspected or confirmed TTP should be screened for the potential presence of cardiac involvement with detailed history and physical,electrocardiogram and cardiac enzymes;(2) clinical deterioration of TTP patients warrants immediate cardiac reevaluation;(3) TTP patients with clinical evidence of cardiac involvement should be monitored for telemetry, cardiac biomarkers and evaluated with transthoracic echocardiography. These patients require urgent targeted TTP treatment as well as cardiac-specific treatment. Aspirin therapy is indicated for all TTP patients. Since epicardial coronary artery involvement is rare, cardiac catheterization is usually not required, given the high risk for hemorrhage and kidney injury;(4) we recommend evidence-based medical therapy for ischemic symptoms and heart failure. TTP patients with evidence of cardiac involvement would also benefit from routine cardiology follow up during remission. 展开更多
关键词 thrombotic THROMBOCYTOPENIC PURPURA Acute myocardial INFARCTION Coronary artery disease anti-PLATELET therapy von Willebrand factor ADAMTS13
下载PDF
On the Construction of Deepening Anti - corruption Mechanism
6
作者 Ding Huanxiang Xuliang 《学术界》 CSSCI 北大核心 2018年第3期260-272,共13页
It needs the foundation of system and the guarantee of organizational system for anti-corruption,but it is more necessary to build and form an effective anti-corruption mechanism,so that the anti-corruption can be rea... It needs the foundation of system and the guarantee of organizational system for anti-corruption,but it is more necessary to build and form an effective anti-corruption mechanism,so that the anti-corruption can be really put into practice. Anti-corruption mechanism refers to a organic operation system of the interaction,interconnection and constraint between the constituent elements( parts) and elements of national anti-corruption,and as a system,anti-corruption mechanism should have the characteristics of system aticness,comprehensiveness,transparency,legalization,public participation,scientific dynam ic,and internationalism. The construction of deepening anti-corruption mechanism is the need for reconstructing the ruling legitimacy of the party and the governm ent. Adhering to the principle of treating both root causes and symptoms is necessary in the construction of anti-corruption m echanism,com bating and punishing corruption is an important part of anti-corruption,and the prevention and control of corruption is the basic project of anti-corruption. Therefore,the construction of prevention and control mechanism in the anti-corruption mechanism has a more far-reaching significance. 展开更多
关键词 anti - CORRUPTION MECHANISM CONSTRUCTION CONNOTATION and definition val-ue analysis prevention and control MECHANISM
下载PDF
Anti-Bacterial and Flame Retardant for Cotton Fabric by One-Bath Finishing
7
作者 朱平 隋淑英 +1 位作者 王炳 孙铠 《Journal of China Textile University(English Edition)》 EI CAS 1998年第2期82-84,共3页
A research on the process of cotton fabric flame-re-tarding,anti-bacterial finishing and one-bath finish-ing of anti-bacterial and flame-retarding is discussed.The flame retardant agent was phosphorous-contained,and t... A research on the process of cotton fabric flame-re-tarding,anti-bacterial finishing and one-bath finish-ing of anti-bacterial and flame-retarding is discussed.The flame retardant agent was phosphorous-contained,and the bacteriostatic finishing agent named SFR-1 wassynthesized.The flame retardancy of the fabric finishedcan meet the DOC FF3-71 Children Sleepwear Stan-dard.Its bacterial inhibiting capacity can meet and ex-ceed the requirements of similar products 展开更多
关键词 cotton fabric flame - RETARDING FINISHING anti - BACTERIAL FINISHING one - BATH
全文增补中
Testing of Anti-stripping Property of Friction Spun Core Yarn
8
作者 丁辛 宋允 《Journal of China Textile University(English Edition)》 EI CAS 1998年第3期66-69,共4页
Friction spun core yarn has two components: filament core and staple fiber sheath. Under axial rubbing action, the failure mode of the core yarn is the stripping of the sheath from the core. This paper introduces a me... Friction spun core yarn has two components: filament core and staple fiber sheath. Under axial rubbing action, the failure mode of the core yarn is the stripping of the sheath from the core. This paper introduces a method to test the anti - stripping property of the core yarn. With a modified Universal Testing Machine, the stripping resistance of friction spun core yarn can be continuously measured. Some factors Influencing the measurements are discussed in detail. The testing results are compared with those from a Y731 Yarn Abrasion Tester and fur - ther confirmed by weaving practice. 展开更多
关键词 FRICTION SPUN CORE YARN anti - STRIPPING PROPERTY STRIPPING resistance testing.
全文增补中
基于网络药理学探讨丹红注射液成分-抗血栓靶点的相互作用 被引量:11
9
作者 李泮霖 刘宏 +3 位作者 廖弈秋 李沛波 姚宏亮 苏薇薇 《中山大学学报(自然科学版)》 CAS CSCD 北大核心 2018年第4期121-127,共7页
采用Surflex-Dock分子对接方法,探讨丹红注射液化学成分与抗血栓靶点间的相互作用,利用Cytoscape软件构建丹红注射液活性成分-抗血栓靶点网络,并通过Clue GO插件对靶点涉及的信号通路进行分析。丹红注射液中有60个成分与106个抗血栓作... 采用Surflex-Dock分子对接方法,探讨丹红注射液化学成分与抗血栓靶点间的相互作用,利用Cytoscape软件构建丹红注射液活性成分-抗血栓靶点网络,并通过Clue GO插件对靶点涉及的信号通路进行分析。丹红注射液中有60个成分与106个抗血栓作用靶点间存在2 028条关联。其中,丹红注射液成分与F2、F13A、SERPINC1、PGH2、ACE、REN、PLAU和PROC等靶点密切相关,这些靶点涉及凝血、纤溶、内皮功能、血管收缩舒张等多方面的信号通路;与抗血栓靶点关联较多的成分为丹酚酸类。这为进一步阐明丹红注射液多成分、多靶点分子作用机制提供了依据。 展开更多
关键词 丹红注射液 分子对接 抗血栓 成分 靶点
下载PDF
高纯度α-亚麻酸抗血栓活性的初步研究 被引量:20
10
作者 杨倩 王四旺 +3 位作者 王剑波 谢艳华 孙纪元 缪珊 《现代生物医学进展》 CAS 2007年第12期1787-1790,1807,共5页
目的:评价从椒目中提取和纯化获得的高纯度α-亚麻酸的抗血栓药理活性。方法:采用小鼠和大鼠在体血栓形成和肺动脉栓塞等模型,分别观察试药对血小板在动-静脉旁路中丝线上的沉积、肺动脉栓塞小鼠的死亡率、体外血小板聚集和出凝血时间... 目的:评价从椒目中提取和纯化获得的高纯度α-亚麻酸的抗血栓药理活性。方法:采用小鼠和大鼠在体血栓形成和肺动脉栓塞等模型,分别观察试药对血小板在动-静脉旁路中丝线上的沉积、肺动脉栓塞小鼠的死亡率、体外血小板聚集和出凝血时间等指标。结果:1.50mg/kg,100mg/kg和250mg/kg高纯度α-亚麻酸及混合不饱和脂肪酸(α-亚麻酸/亚油酸=1/1)给小鼠灌胃治疗10天,显著延长出、凝血时间(P<0.01);明显降低胶原蛋白-肾上腺素诱发性肺动脉栓塞小鼠的死亡率(P<0.01)。2、35mg/kg,70mg/kg和175mg/kg高纯度α-亚麻酸及混合不饱和脂肪酸给大鼠灌胃治疗10天,明显抑制血小板在动-静脉旁路中丝线上的沉积(P<0.01)和大鼠体外血小板聚集(P<0.01)。结论:从椒目中提纯的高纯度α-亚麻酸,作为一种木本油脂新的药用资源和其混合不饱和脂肪酸均具有明显抗血小板聚集和溶栓药理作用,并具有一定量效关系;同时还发现,当α-亚麻酸/亚油酸=1/1时,其抗血栓药理活性优于同剂量高纯度的α-亚麻酸。 展开更多
关键词 中药 椒目 Α-亚麻酸 不饱和脂肪酸 抗血栓作用
下载PDF
Menstrual Abnormalities and Gynaecological Problems in Women on Anticoagulant and Antiplatelet Therapy: Management Options 被引量:1
11
作者 Pratibha Devabhaktuni Precella Thomas +2 位作者 Anuj Kapadia Sridevi   Somaraju Bhupatiraju 《Open Journal of Obstetrics and Gynecology》 2017年第5期581-599,共19页
Introduction: The aim of this study was: 1) To study the pattern of menstrual abnormality and severity in women on anticoagulant and antiplatelet drugs. 2) To analyze the correlation of prothrombin time (PT), Internat... Introduction: The aim of this study was: 1) To study the pattern of menstrual abnormality and severity in women on anticoagulant and antiplatelet drugs. 2) To analyze the correlation of prothrombin time (PT), International Normalised ratio (INR) and the bleeding severity. 3) To discuss the various management options in unexpected emergencies and menstrual complications in this subset of women on anticoagulants. Material & Methods: It is a prospective study, over a period of 18 months from July 2011 to december 2012. We had 44 women on antithrombotic therapy. 32 women were on anticoagulants and 12 were on antiplatelet agents. The severity of bleeding pattern was assessed with pictoral bleeding assessment chart (PBAC). 1) Out of 44 women studied, 32 women were on anticoagulants and 12 were on antiplatelet agents. 26 (81.25%) were on acenocoumarol, 5 (15.62%) on warfarin, 1 (3.12%) on heparin, among the 12 antiplatelet users, 8 (66.66%) were on aspirin and 4 (33.33%) on clopidogrel. 2) The indication for anticoagulants was mitral valve replacement (MVR) in 9, double valve replacement (DVR) in 6, aortic valve replacement (AVR) in 3, severe pulmonary artery hypertension (PAH) in 2, severe mitral stenosis (MS) with atrial thrombus in 2, deep vein thrombosis (DVT) in 5, severe mitral regurgitation (MR) in one, the other indications were subdural hematoma, thromboendarterectomy, chronic kidney disease (CKD) stage V, coarction of aorta, one each. The indication for antiplatelet therapy was percutaneous transluminal coronary angioplasty (PTCA) in 3, Wolf Parkinson White (WPW) syndrome + atrial fibrillation (AF), acute myocardial infarction (AMI), coronary artery bypass graft (CABG), mid basilar artery aneurysm, renal allograft recipient, dialated cardiomyopathy, aortic aneurysm repair, hypertension and unstable angina one each. Results: In women on anticoagulants (32), the main complaint was menorrhagia/heavy menstrual bleeding (HMB) in 20, polymenorrhoea with menorrhagia in 4, continuous per vaginal (PV) bleeding in 6. One lady had postmenopausal bleeding. Among the 12 antiplatelet users the main complaint was menorrhagia in 8, polymenorrhoea with menorrhagia in 2, postmenopausal bleeding in one. While on antithrombotic therapy apart from heavy menstrual bleeding, two women had intraperitoneal bleeding, two had post menopausal bleeding, two had secondary postpartum bleeding (PPH). CVA due to embolic stroke occurred in three, one during the study period. Subchoroidal haemorrhage causing choroidal detachment was noted in one. Conclusions: In patients with prolonged INR, excessive uterine bleeding can be an alerting initial manifestation. Antithrombotic therapy can cause HMB or exaggerate the symptom of HMB due to an underlying gynaec pathology. Mefanamic acid and norethisterone were used to arrest heavy menstrual bleeding. Antithrombotic therapy in women needs special consideration with alterations in menstrual pattern and contraception. Pregnancy and postpartum period present special challenges. 展开更多
关键词 anti thrombotic Therapy in WOMEN antiCOAGULANTS HMB PMB PPH
下载PDF
应用光-化学法血栓生成模型研究急慢性疗法下阿司匹林的抗血栓作用
12
作者 徐蕾 连杰 郑筱祥 《微循环学杂志》 1998年第2期14-15,共2页
采用光—化学法在大鼠肠系膜微静脉建立活体血栓生成模型,研究了在急性(一次用药)与慢性(每日给药,一周)条件下阿司匹林的抗血栓作用。慢性阿司匹林用药组与生理盐水对照组相比,可以明显减缓血栓生长速度,延长血栓栓塞时间,表... 采用光—化学法在大鼠肠系膜微静脉建立活体血栓生成模型,研究了在急性(一次用药)与慢性(每日给药,一周)条件下阿司匹林的抗血栓作用。慢性阿司匹林用药组与生理盐水对照组相比,可以明显减缓血栓生长速度,延长血栓栓塞时间,表明阿司匹林对血栓形成有一定的抑制作用。 展开更多
关键词 阿司匹林 抗血栓作用 药理实验
下载PDF
凝血酶GPIb-Ⅸ-Ⅴ受体作用机制及相关药物研究进展
13
作者 崔双 龚国清 《药学研究》 CAS 2017年第3期157-160,共4页
凝血酶是凝血瀑布中的重要位点,在止血与凝血中扮演着重要角色。凝血酶与血小板膜受体GPIb-Ⅸ-Ⅴ结合可以介导血小板活化,促进血栓生成。本文通过查阅相关文献,对凝血酶和GPIb-Ⅸ-Ⅴ受体的结构、作用机制进行相关介绍,并将近年来针对凝... 凝血酶是凝血瀑布中的重要位点,在止血与凝血中扮演着重要角色。凝血酶与血小板膜受体GPIb-Ⅸ-Ⅴ结合可以介导血小板活化,促进血栓生成。本文通过查阅相关文献,对凝血酶和GPIb-Ⅸ-Ⅴ受体的结构、作用机制进行相关介绍,并将近年来针对凝血酶和GPIb-Ⅸ-Ⅴ受体为治疗靶点的新型抗血栓制剂进行综述,期望对血栓治疗提供新思路。 展开更多
关键词 凝血酶 GPIb--Ⅴ受体 新型抗血栓制剂
下载PDF
<i>In Vivo</i>and <i>in Vitro</i>Evaluation of Anti Diabetic and Insulin Secretagogue Activities of <i>Capparis zeylanica</i>
14
作者 Umamahesh Balekari Ciddi Veeresham 《Pharmacology & Pharmacy》 2015年第7期311-320,共10页
Since ancient times, traditional medicines have been in the usage for the treatment of Diabetes mellitus. An edible fruit from traditional medicinal plant Capparis zeylanica (CZ) was studied for its anti diabetic, ins... Since ancient times, traditional medicines have been in the usage for the treatment of Diabetes mellitus. An edible fruit from traditional medicinal plant Capparis zeylanica (CZ) was studied for its anti diabetic, insulin secretagogue activities and mechanisms involved in it. In Streptozotocin induced diabetes rats, oral administration of Capparis zeylanica methanolic extract (CZME) (200 mg/kg body weight) for 28 days showed a significant reduction in blood glucose levels by 35.53% and enhanced circulating insulin levels by 81.82% than the diabetic control rats. The insulin secretagogue activity mechanisms of the extract were evaluated by using mouse insulinoma beta cell line (MIN6-β). The extract stimulated insulin release in dependent manner of glucose concentration (3 - 16.7 mM) and extract dose (5 - 500 μg/mL). The insulin releasing effect of the extract was significantly enhanced by 3-isobutyl-1-methyl xanthine, glibenclamide, elevated extracellular calcium and K+ depolarized media. This insulin release was significantly reduced in calcium blocking conditions (by nifedipine and EGTA), in the presence of potassium channel opener (diazoxide). Hence, anti diabetic activity of CZME might be a result of its stimulatory effect on insulin release from pancreatic beta cells via KATP channel dependent and independent ways. These results indicate that CZ fruits have the potential to use in diabetes therapy. 展开更多
关键词 anti DIABETIC INSULIN Secretagogue MIN6-β Cells KATP Channel
下载PDF
Exact Traveling Wave Solutions of Nano-Ionic Solitons and Nano-Ionic Current of MTs Using the exp(-φ (ξ ))-Expansion Method
15
作者 Emad H. M. Zahran 《Advances in Nanoparticles》 2015年第2期25-36,共12页
In this work, the exp(-φ (ξ )) -expansion method is used for the first time to investigate the exact traveling wave solutions involving parameters of nonlinear evolution equations. When these parameters are taken to... In this work, the exp(-φ (ξ )) -expansion method is used for the first time to investigate the exact traveling wave solutions involving parameters of nonlinear evolution equations. When these parameters are taken to be special values, the solitary wave solutions are derived from the exact traveling wave solutions. The validity and reliability of the method are tested by its applications to Nano-ionic solitons wave’s propagation along microtubules in living cells and Nano-ionic currents of MTs which play an important role in biology. 展开更多
关键词 The exp(-φ )) -Expansion Method Nano-Solitons of IONIC Wave’s Propagation along Microtubules in Living Cells Nano-Ionic Currents of MTS Traveling WAVE SOLUTIONS KINK and anti KINK WAVE SOLUTIONS
下载PDF
抗栓治疗后血小板参数对非心源性脑梗死预后的预测价值研究
16
作者 徐迎春 《中国实用医药》 2024年第14期15-19,共5页
目的研究抗栓治疗后血小板参数对非心源性脑梗死(NCCI)预后的预测价值。方法71例NCCI患者,所有患者均于入院首日抗栓之前完成血小板参数[血小板分布宽度(PDW)、平均血小板体积(MPV)、血小板计数(PLT)、PDW/PLT、MPV/PLT]测定。抗栓7 d后... 目的研究抗栓治疗后血小板参数对非心源性脑梗死(NCCI)预后的预测价值。方法71例NCCI患者,所有患者均于入院首日抗栓之前完成血小板参数[血小板分布宽度(PDW)、平均血小板体积(MPV)、血小板计数(PLT)、PDW/PLT、MPV/PLT]测定。抗栓7 d后,所有NCCI患者均完善PDW、MPV、PLT、PDW/PLT、MPV/PLT复查,分别以PLT7、PDW7、MPV7、MPV7/PLT7、PDW7/PLT7表示。选取改良Rankin量表(MRS)对患者6个月时神经功能恢复情况做出评估,根据预后评估结果分为预后不良组(MRS评分>2分,10例)与预后良好组(MRS评分≤2分,61例)。①比较两组一般资料及血化验结果;②采用多因素Logistic回归分析NCCI患者抗栓7 d后预后不良的危险因素;③采用受试者工作特征曲线(ROC曲线)分析阳性指标对NCCI患者预后的预测价值。结果抗栓后,61例患者预后良好,10例患者预后不良。两组患者年龄、性别、饮酒、吸烟、冠心病、糖尿病、高血压、白细胞计数、尿酸、尿素氮、肌酐、同型半胱氨酸、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、甘油三酯、总胆固醇、MPV、PDW、PLT7、PDW/PLT水平比较差异无显著性(P>0.05)。预后不良组患者PLT(157.72±46.53)×10^(9)/L明显低于预后良好组的(195.04±55.42)×10^(9)/L,MPV/PLT(0.77±0.14)×10^(-10)fl/L明显高于预后良好组的(0.61±0.23)×10^(-10)fl/L,差异有显著性(P<0.05);预后不良组患者MPV7、MPV7/PLT7、PDW7、PDW7/PLT7分别为(14.72±4.07)fl、(0.73±0.23)×10^(-10)fl/L、(11.63±1.48)fl、(0.92±0.39)×10^(-10)fl/L,明显高于预后良好组的(12.29±3.26)fl、(0.52±0.21)×10^(-10)fl/L、(9.81±1.58)fl、(0.71±0.25)×10^(-10)fl/L,差异有显著性(P<0.05)。将单因素分析中显示差异有显著性的因素(PLT、MPV/PLT、PDW7、PDW7/PLT7、MPV7、MPV7/PLT7)纳入多因素Logistic回归分析,结果显示:MPV7为NCCI患者预后不良的危险因素[OR=7.668,95%CI=(1.526,38.527),P=0.012<0.05]。ROC曲线显示:MPV7对NCCI患者的预后具有预测价值,以10.13 fl为临界值,MPV7预测NCCI患者预后不良的曲线下面积(AUC)为0.786[95%CI=(0.677,0.896),P=0.001<0.05],灵敏度为83.33%,特异度为69.50%。结论抗栓7 d后MPV为NCCI患者预后不良的危险因素,可辅助预测NCCI预后情况。 展开更多
关键词 非心源性脑梗死 抗栓治疗 血小板分布宽度 平均血小板体积 血小板计数
下载PDF
红花中的黄酮类化学成分及其药理作用研究进展 被引量:9
17
作者 李阳 焦扬 牛洁 《环球中医药》 CAS 2024年第1期137-143,共7页
红花为菊科属植物红花Carthamus tinctorius L.的干燥花,黄酮类化学成分是红花特征性和主要的活性成分,依据结构类型主要分为四类,包括黄酮、黄酮醇、二氢黄酮、醌式查耳酮类。现代药理学研究表明,红花黄酮类化学成分药理作用广泛,如降... 红花为菊科属植物红花Carthamus tinctorius L.的干燥花,黄酮类化学成分是红花特征性和主要的活性成分,依据结构类型主要分为四类,包括黄酮、黄酮醇、二氢黄酮、醌式查耳酮类。现代药理学研究表明,红花黄酮类化学成分药理作用广泛,如降低血液粘度、减轻血管内皮炎症损伤、抑制炎症因子释放、改善气道重塑、抑制心肌细胞凋亡、保护中枢神经、保肝等,对多系统疾病具有治疗作用。本文通过检索国内外文献,对红花黄酮类化学成分及其药理作用的研究进展进行综述,为红花的进一步研究提供参考。 展开更多
关键词 红花 黄酮类化学成分 药理作用 研究进展 抗血栓 抗炎
下载PDF
心房颤动患者经皮冠状动脉介入后的抗血栓潜在生物标志物和治疗靶点的综合分析
18
作者 李景瑞 吴晓杰 +2 位作者 信鸿巍 张百会 丁园园 《智慧健康》 2024年第13期48-50,共3页
目的探究治疗靶点对于房颤患者经皮冠状动脉介入术(PCI)后血栓形成的预测效能。方法选择某医院2022年7月—2023年7月收治的120例进行PCI术治疗的房颤患者为研究对象,根据术后14d内是否出现血栓将其分为血栓组(44例)和无血栓组(76例)。... 目的探究治疗靶点对于房颤患者经皮冠状动脉介入术(PCI)后血栓形成的预测效能。方法选择某医院2022年7月—2023年7月收治的120例进行PCI术治疗的房颤患者为研究对象,根据术后14d内是否出现血栓将其分为血栓组(44例)和无血栓组(76例)。收集对比两组的一般临床资料,分析影响房颤患者PCI术后血栓形成的危险因素,探究关键性靶点的临床预测效能。结果与无血栓组相比,血栓组原发性高血压患者占比、vWT和D-D水平更高,差异有统计学意义(P<0.05),两组其余资料比较,差异无统计学意义(P>0.05);原发性高血压、vWF和D-D水平是房颤患者PCI术后出现血栓的独立危险因素,差异有统计学意义(P<0.05)。结论临床对存在原发性高血压病史的患者及其vWT和D-D水平进行密切监测,可有效预测房颤患者PCI术后发生血栓的可能性,改善患者预后。 展开更多
关键词 心房颤动 经皮冠状动脉介入 抗血栓 关键性靶点
下载PDF
气压治疗联合抗血栓梯度袜使用对肢体深静脉血栓形成物理预防效果观察
19
作者 金超 金黑鹰 《罕少疾病杂志》 2024年第9期120-122,共3页
目的 分析结直肠癌术后患者使用气压治疗联合抗血栓梯度袜对肢体深静脉血栓形成(DVT)的物理预防效果。方法 选取我院肛肠科2018年3月~2023年3月60例经DVT(Autar)评估为中风险的结直肠癌术后患者,依据术后DVT预防措施不同分为两组各30例... 目的 分析结直肠癌术后患者使用气压治疗联合抗血栓梯度袜对肢体深静脉血栓形成(DVT)的物理预防效果。方法 选取我院肛肠科2018年3月~2023年3月60例经DVT(Autar)评估为中风险的结直肠癌术后患者,依据术后DVT预防措施不同分为两组各30例。对照组采取传统DVT预防措施,观察组加用气压治疗联合抗血栓梯度袜物理预防干预,24小时内监督下床活动。分别在干预前、干预后1周监测血凝指标,于患者出院前统计DVT发生情况及专科护理服务满意情况。结果 干预后1周两组的血凝指标均优于干预前且观察组优于对照组(P<005)。两组出院前均无DVT发生(P>005)。观察组专科护理服务总满意率高于对照组(P<005)。结论 气压治疗联合抗血栓梯度袜使用物理预防干预措施可明显预防结直肠癌术后患者DVT形成,有效改善凝血功能,值得推广使用。 展开更多
关键词 结直肠癌 术后 气压治疗 抗血栓梯度袜 物理干预 肢体深静脉血栓形成 凝血功能 满意率
下载PDF
低分子肝素联合抗血栓压力带对胸部创伤后发生静脉血栓栓塞症的影响
20
作者 胡淼 张冬 程志远 《血管与腔内血管外科杂志》 2024年第5期536-539,568,共5页
目的探讨低分子肝素联合抗血栓压力带对胸部创伤后发生静脉血栓栓塞症(VTE)的影响。方法收集2021年6月至2023年9月首都医科大学附属北京积水潭医院收治的298例胸部创伤患者的临床资料,按照治疗方法的不同将其分为联合组(n=162,使用低分... 目的探讨低分子肝素联合抗血栓压力带对胸部创伤后发生静脉血栓栓塞症(VTE)的影响。方法收集2021年6月至2023年9月首都医科大学附属北京积水潭医院收治的298例胸部创伤患者的临床资料,按照治疗方法的不同将其分为联合组(n=162,使用低分子肝素联合抗血栓压力带进行VTE预防)和对照组(n=136,仅使用低分子肝素进行VTE预防)。记录两组患者手术过程中的相关指标,比较两组患者术后住院期间VTE的发生率、术后并发症的发生情况。结果两组患者均以开放性创伤、合并肺损伤为主,少数患者存在意识障碍。两组患者创伤情况、手术相关指标比较,差异均无统计学意义(P﹥0.05)。住院期间共13例患者发生VTE,其中,联合组患者VTE发生率为1.8%(3/162),低于对照组患者的7.3%(10/136),差异有统计学意义(P﹤0.05)。两组患者其他并发症发生率比较,差异均无统计学意义(P﹥0.05)。结论低分子肝素联合抗血栓压力带可以安全、有效地降低胸部创伤患者术后发生VTE的风险,值得在临床上进一步推广应用。 展开更多
关键词 低分子肝素 抗血栓压力带 胸部创伤 静脉血栓栓塞症 预防
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部